REFERENCES 1. Abbas M, de Kraker MEA, Aghayev E, Astagneau P, Aupee M, Behnke M, et al. Impact of participation in a surgical site infection surveillance network: results from a large international cohort study. J Hosp Infect. 2019;102(3):267‐76 https://doi.org/10.1016/j.jhin.2018.12.003. 2. Centers for Disease Control and Prevention (CDC). About NHSN [Available from: https://www.cdc.gov/nhsn/about‐nhsn/index.html. 3. Rosenthal VD, Duszynska W, Ider BE, Gurskis V, Al‐Ruzzieh MA, Myatra SN, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013‐2018, Adult and Pediatric Units, Device‐associated Module. Am J Infect Control. 2021;49(10):1267‐74 https://doi.org/10.1016/j.ajic.2021.04.077. 4. Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al‐Mousa HH, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007‐2012. Device‐associated module. Am J Infect Control. 2014;42(9):942‐56 https://doi.org/10.1016/j.ajic.2014.05.029. 5. Schröder C, Schwab F, Behnke M, Breier AC, Maechler F, Piening B, et al. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance. Int J Med Microbiol. 2015;305(7):799‐ 806 https://doi.org/10.1016/j.ijmm.2015.08.034. 6. Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006;64(1):16‐ 22 https://doi.org/10.1016/j.jhin.2006.04.017. 7. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121(2):182‐205 https://doi.org/10.1093/oxfordjournals.aje.a113990. 8. Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in Prevalence of Health Care‐Associated Infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732‐44 https://doi.org/10.1056/NEJMoa1801550. 9. Badia‐Cebada L, Penafiel J, Saliba P, Andres M, Camara J, Domenech D, et al. Trends in the epidemiology of catheter‐related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019. Euro Surveill. 2022;27(19) https://doi.org/10.2807/1560‐7917.ES.2022.27.19.2100610. 10. Centers for Disease Control and Prevention (CDC). Bloodstream Infection Event (Central Line‐ Associated Bloodstream Infection and Non‐central Line Associated Bloodstream Infection) Atlanta, USA: Centers for Disease Control and Prevention; 2023 [Available from: https://www.cdc.gov/nhsn/psc/bsi/. 11. Sickbert‐Bennett E.E. D, L.M. Infectious disease surveillance in healthcare settings. In: Weber D.J. TTR, editor. Mayhall's hospital epidemiology and infection control. Fifth edition ed. Philadelphia: Wolters Kluwer; 2021. 12. Mannien J, van der Zeeuw AE, Wille JC, van den Hof S. Validation of surgical site infection surveillance in the Netherlands. Infect Control Hosp Epidemiol. 2007;28(1):36‐41 https://doi.org/10.1086/509847. 13. Reilly JS, Price L, Godwin J, Cairns S, Hopkins S, Cookson B, et al. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare‐associated infections and antimicrobial use in acute hospitals in Europe, 2011. Euro Surveill. 2015;20(8) https://doi.org/10.2807/1560‐ 7917.es2015.20.8.21045. 14. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare‐ associated infections and antimicrobial use in European acute care hospitals, 2011‐2012. 2013. 252 Chapter 10
RkJQdWJsaXNoZXIy MTk4NDMw